Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction

NCT04309994 · clinicaltrials.gov ↗

COMPLETED

Status

307

Enrollment

OTHER

Sponsor class

Conditions

Heart Attack
Cardioplegia Solution Adverse Reaction
Coronary Artery Bypass Grafting (CABG)

Interventions

OTHER: Myocardial protection system (MPS)
OTHER: Cardioplexol

Sponsor

University Hospital, Basel, Switzerland